Company Analysis

Allarity Therapeutics, Inc. (ALLR)

Nasdaq: ALLR · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2021
Grade3.4
◀ Past 2.4● Present 1.8▶ Future 5.4
4 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

0 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Allarity Therapeutics, Inc.’s names, not what it holds today.

Patents granted
0
by type: not read, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
1
since 2001, to Dec 31, 2025
Names they are printed under
1
its own name
By yearGrantedApplications published
'24
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name1 counted
Allarity Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
1 published
Names not counted (2)
Medical Prognosis Institute, Inc.*
Most of its patents print DK; this name counts in US. 4 granted and 3 published under it are not counted.
Medical Prognosis Institute, Inc.*
Most of its patents print DK; this name counts in US. 0 granted and 3 published under it are not counted.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 3, 20242024/0325396METHODS FOR TREATING CANCERPharmaceuticalsAllarity Therapeutics, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ALLR · research, not advice